NuGen Medical Devices Inc. NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.52M | -7.95M | -5.67M | -1.58M | -2.40M |
| Total Depreciation and Amortization | 293.20K | 506.40K | 494.80K | 464.30K | 455.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.33M | 4.75M | 2.78M | -1.09M | -979.20K |
| Change in Net Operating Assets | -143.00K | -20.00K | -156.80K | -1.63M | -814.00K |
| Cash from Operations | -3.03M | -2.72M | -2.55M | -3.84M | -3.73M |
| Capital Expenditure | -181.40K | -396.20K | -179.50K | -62.10K | -7.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -205.30K | -78.20K | -39.30K | -39.40K | -38.90K |
| Cash from Investing | -386.70K | -474.40K | -218.80K | -101.50K | -46.30K |
| Total Debt Issued | -- | -- | -- | 0.00 | 10.00M |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 60.50K | 465.50K | 530.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 42.20K | 331.50K | 7.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.42M | -3.19M | -2.73M | -3.61M | 3.93M |